Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer

• Guru Sonpavde,
• Na Li,
• Zheng Zhu,
• Fan Cheng,
• Shaoming Zhu,
• A-Hong Ma,
• Elio Adib,
• Ting Rao,
• Kaiyuan Ni,
• Veera Chandra Sekhar Reddy Chittepu,
• Rao Prabhala,
• Juan Garisto Risco,
• David Kwiatkowski,
• Kent Mouw,
• Chong-xian Pan

Affiliations

Guru Sonpavde

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Na Li

Department of Internal Medicine, University of California Davis, Sacramento, CA, USA

Zheng Zhu

Department of Medicine, Harvard Medical School, Boston, MA, USA

Fan Cheng

Department of Urology, Renmin Hospital of Wuhan University, Wuhan, People`s Republic of China

Shaoming Zhu

Department of Internal Medicine, University of California Davis, Sacramento, CA, USA

A-Hong Ma

Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, CA, USA

Elio Adib

Department of Medicine, Harvard Medical School, Boston, MA, USA

Ting Rao

Department of Internal Medicine, University of California Davis, Sacramento, CA, USA

Kaiyuan Ni

Department of Bioengienering, Massachusetts Institute of Technology, Cambridge, MA, USA

Veera Chandra Sekhar Reddy Chittepu

Department of Medicine, Harvard Medical School, Boston, MA, USA

Rao Prabhala

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Juan Garisto Risco

Department of Urology, VA Boston Healthcare System, Boston, MA, USA

David Kwiatkowski

Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

Kent Mouw

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Chong-xian Pan

Department of Internal Medicine, University of California Davis, Sacramento, CA, USA